Cargando…

Therapeutic approaches for SARS-CoV-2 infection

Therapeutic approaches to COVID-19 treatment require appropriate inhibitors to target crucial proteins of SARS-CoV-2 replication machinery. It’s been approximately 12 months since the pandemic started, yet no known specific drugs are available. However, research progresses with time in terms of high...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Ankur, Pradhan, Anish, Maurya, Vimal K., Kumar, Swatantra, Theengh, Angila, Puri, Bipin, Saxena, Shailendra K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096528/ https://www.ncbi.nlm.nih.gov/pubmed/33962011 http://dx.doi.org/10.1016/j.ymeth.2021.04.026

Ejemplares similares

Host Immune Response and Immunobiology of Human SARS-CoV-2 Infection
por: Kumar, Swatantra, et al.
Publicado: (2020)

Morphology, Genome Organization, Replication, and Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
por: Kumar, Swatantra, et al.
Publicado: (2020)

Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV)
por: Kumar, Swatantra, et al.
Publicado: (2020)

Chasing COVID-19 through SARS-CoV-2 spike glycoprotein
por: Saxena, Shailendra K., et al.
Publicado: (2020)

Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor
por: Maurya, Vimal K., et al.
Publicado: (2020)

Structural and molecular perspectives of SARS-CoV-2
por: Kumar, Swatantra, et al.
Publicado: (2021)

Therapeutic Development and Drugs for the Treatment of COVID-19
por: Maurya, Vimal K., et al.
Publicado: (2020)

Progress and Challenges Toward Generation and Maintenance of Long-Lived Memory T Lymphocyte Responses During COVID-19
por: Kumar, Swatantra, et al.
Publicado: (2022)

Current Insight into the Novel Coronavirus Disease 2019 (COVID-19)
por: Saxena, Shailendra K., et al.
Publicado: (2020)

Recombinant vaccines for COVID-19
por: Yadav, Tushar, et al.
Publicado: (2020)

An Ophthalmological update for air-travellers during COVID-19
por: Pandey, Nitika, et al.
Publicado: (2021)

Transmission Cycle of SARS-CoV and SARS-CoV-2
por: Yadav, Tushar, et al.
Publicado: (2020)

Correction to: Transmission Cycle of SARS-CoV and SARS-CoV-2
por: Yadav, Tushar, et al.
Publicado: (2020)

Laboratory Diagnosis of Novel Coronavirus Disease 2019 (COVID-19) Infection
por: Padhi, Abhishek, et al.
Publicado: (2020)

Prevention and Control Strategies for SARS-CoV-2 Infection
por: Srivastava, Nishant, et al.
Publicado: (2020)

Tracking the COVID-19 vaccines: The global landscape
por: Yadav, Tushar, et al.
Publicado: (2023)

Preparing for the Perpetual Challenges of Pandemics of Coronavirus Infections with Special Focus on SARS-CoV-2
por: Chawla, Sonam, et al.
Publicado: (2020)

Host Cell and SARS-CoV-2-Associated Molecular Structures and Factors as Potential Therapeutic Targets
por: Chaudhary, Jitendra Kumar, et al.
Publicado: (2021)

The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach
por: Morris, Gerwyn, et al.
Publicado: (2020)

Fabrication and Evaluation of Basil Essential Oil-Loaded Halloysite Nanotubes in Chitosan Nanocomposite Film and Its Application in Food Packaging
por: Chaudhary, Narayan, et al.
Publicado: (2022)

SARS-CoV-2 IgG Surveillance in Asymptomatic Blood Donors and Health Workers
por: Chandra, Tulika, et al.
Publicado: (2021)

Present therapeutic and diagnostic approaches for SARS-CoV-2 infection
por: Gupta, Sayan Dutta, et al.
Publicado: (2022)

Viral Hepatitis E and Chronicity: A Growing Public Health Concern
por: Thakur, Vikram, et al.
Publicado: (2020)

Destruction mechanisms of ozone over SARS-CoV-2
por: Ataei-Pirkooh, Angila, et al.
Publicado: (2021)

Seropositivity of Anti-SARS CoV2 IgG antibodies in health care workers of an Indian tertiary care hospital during COVID-19
por: Verma, Anuragani, et al.
Publicado: (2022)

Amyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes
por: Bhardwaj, Taniya, et al.
Publicado: (2023)

Is SARS-CoV-2 a concern in the largest wastewater treatment plant in middle east?
por: Pasalari, Hasan, et al.
Publicado: (2023)

Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19
por: Yadav, Rohitash, et al.
Publicado: (2021)

Vaping, SARS-CoV-2, and Multisystem Inflammatory Syndrome: A Perfect Storm
por: Brar, Esha, et al.
Publicado: (2021)

Comparative analysis of non structural protein 1 of SARS-CoV2 with SARS-CoV1 and MERS-CoV: An in silico study
por: Chaudhuri, Ankur
Publicado: (2021)

Current Potential Therapeutic Approaches against SARS-CoV-2: A Review
por: Yadav, Dharmendra Kumar, et al.
Publicado: (2021)

SARS-CoV-2 pandemic and pediatric endoscopic surgery
por: Saxena, Amulya K.
Publicado: (2020)

Relevant of neutralizing antibody during SARS-CoV-2 infection and their therapeutic usage
por: Gupta, Sneh Lata, et al.
Publicado: (2022)

Current status of therapeutic approaches and vaccines for SARS-CoV-2
por: Wahid, Braira, et al.
Publicado: (2021)

Combinatory therapeutic approaches for common cold and SARS-CoV-2
por: Anbalagan, Sankarappan, et al.
Publicado: (2020)

On aerosol transmission of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2021)

Design and identification of novel annomontine analogues against SARS-CoV-2: An in-silico approach
por: Waidha, Kamran, et al.
Publicado: (2021)

SARS-CoV-2 detection with aptamer-functionalized gold nanoparticles
por: Aithal, Srivatsa, et al.
Publicado: (2022)

Gasless laparoscopy revisited in the SARS-CoV-2 pandemic
por: Abdelbaset, Ahmed Ali, et al.
Publicado: (2020)

Animal models for SARS-CoV-2 and SARS-CoV-1 pathogenesis, transmission and therapeutic evaluation
por: Saravanan, Udhaya Bharathy, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8en8g9cn4poraqjavadfq618l3